ArticleNature reviews. Drug discovery2014
Trial watch: global migration of clinical trials.
Article in Nature reviews. Drug discovery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- iGraphCTC: an inter-connected graph convolutional network for comprehensive clinical trial collaborations.Scientific reports · 2026Article
- The long-term impact of vaccine clinical research on national stakeholders involved: Experience from a low-income Country.Human vaccines & immunotherapeutics · 2025Article
- Quality of Drug Clinical Trials in China: A Mixed Methods Research.Journal of evidence-based medicine · 2025Article
- Towards achieving transnational research partnership equity: lessons from implementing adaptive platform trials in low- and middle-income countries.Wellcome open research · 2023Article
- Globalisation of industry-sponsored clinical trials for breast, lung and colon cancer research: trends, threats and opportunities.BMJ oncology · 2023Article
- Current scenario and future perspectives of clinical research in Brazil: a national survey.Ecancermedicalscience · 2023Article
- Leveraging WHO's Global Benchmarking Tool to strengthen capacity in clinical trials oversight for public health emergencies: the GHPP VaccTrain model.Globalization and health · 2022Article
- Quantifying geographical accessibility to cancer clinical trials in different income landscapes.ESMO open · 2022Article
- Ethical Issues in Conducting Cross-Cultural Research in Low-Income Countries: A Pakistani Perspective.Asian bioethics review · 2022Article
- Are We Scared of Clinical Trials if Not Sufficiently Informed and Educated?Advances in medical education and practice · 2022Article
- The Pivotal Role of Quality Technical Structures for Clinical Trials Oversight in the Achievement of Long-Term Capacity Strengthening Outcomes.Frontiers in medicine · 2022Article
- The Future of Clinical Trial Design in Oncology.Cancer discovery · 2021Review
- Regional variations in adverse event reporting rates and ACR responses in placebo/standard-of-care arms of rheumatoid arthritis trials.Rheumatology (Oxford, England) · 2020Observational
- Scientific considerations for global drug development.Science translational medicine · 2020Review
- Regulating international clinical research: an ethical framework for policy-makers.BMJ global health · 2020Review
- Analysis of Global Drug Development Pathways and Postmarketing Safety in Japan: Local Studies May Reduce Drug-Related Deaths.Clinical and translational science · 2019Article
- Participants' awareness of ethical compliance, safety and protection during participation in pharmaceutical industry clinical trials: a controlled survey.BMC medical ethics · 2019Article
- Demographic Composition of Select Oncologic New Molecular Entities Approved by the FDA Between 2008 and 2017.Clinical pharmacology and therapeutics · 2018Article
- The patient's safety and access to experimental drugs after the termination of clinical trials: regulations and trends.European journal of clinical pharmacology · 2018Article
- Racial and Ethnic Composition of Cancer Clinical Drug Trials: How Diverse Are We?The oncologist · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.